Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical – Page 422

The repair of damage to genetic material (DNA) in the human body is carried out by highly efficient mechanisms that have not yet been fully researched. A scientific team led by Christian Seiser from MedUni Vienna’s Center for Anatomy and Cell Biology has now discovered a previously unrecognized control point for these processes.

This discovery could lead to a new approach for the development of cancer therapies aimed at inhibiting the repair of damaged . The research work was recently published in the journal Nucleic Acids Research.

GSE1-CoREST is the name of the newly discovered complex that contains three enzymes that control DNA repair processes and could form the basis for novel cancer therapeutics. “In research, these proteins are already associated with cancer, but not in the context that we have now found,” emphasizes Seiser, who led the study in close collaboration with researchers from the Max Perutz Labs Vienna.

Read more | >

With depression affecting around 1 in 10 of us at some point during our lives, the need for new and improved treatments is a top priority for researchers – and it appears that spinal cord stimulation could be one route for experts to investigate.

A team led by researchers at the University of Cincinnati College of Medicine devised a pilot clinical trial in which a little black box was placed on the spinal cord of 20 volunteers with depression, with one electrode on the back and one on the right shoulder.

The box then delivered a specially customized, low-level electric buzz to half of the volunteers, for three sessions per week over eight weeks. This was shown to have a greater effect on depressive symptoms than the different, ‘placebo’ charge administered to the other half of the volunteers.

Read more | >

Discovery could be useful in developing new therapies for multiple sclerosis, neurodegenerative conditions, and brain cancer.

New research from Oregon Health & Science University for the first time reveals the function of a little-understood junction between cells in the brain that could have important treatment implications for conditions ranging from multiple sclerosis to Alzheimer’s disease, to a type of brain cancer known as glioma.

The study will be published today (January 12) in the journal Nature Neuroscience.

Read more | >

Department of Energy user facility helps probe questions from changes in the structure of nuclei to nuclear reactions that shape the Universe.

The Facility for Rare Isotope Beams (FRIB) enables discoveries in the science of atomic nuclei, their role in the cosmos, and the fundamental symmetries of nature. This accelerator facility uses beams of short-lived nuclei not available elsewhere. Results from FRIB address questions such as the limits of the nuclear chart, the origin of the elements, and the reason for why there is more matter than antimatter in our Universe.

In FRIB’s first year, its measurements tackled the changes in the structure of the shortest-lived nuclei, exotic decay modes, nuclear reactions that affect cosmic events such as X-ray bursts, and processes in the crusts of neutron stars.

Read more | >

Stanford Medicine scientists used transcranial magnetic stimulation to temporarily enhance hypnotizability in patients with chronic pain, making them better candidates for hypnotherapy.

How deeply someone can be hypnotized — known as hypnotizability — appears to be a stable trait that changes little throughout adulthood, much like personality and IQ. But now, for the first time, Stanford Medicine researchers have demonstrated a way to temporarily heighten hypnotizablity — potentially allowing more people to access the benefits of hypnosis-based therapy.

In the new study, published on January 4 in Nature Mental Health, the researchers found that less than two minutes of electrical stimulation targeting a precise area of the brain could boost participants’ hypnotizability for about one hour.

Read more | >

When learning, patients with schizophrenia or depression have difficulty making optimal use of information that is new to them. In the learning process, both groups of patients give greater weight to less important information and, as a result, make less than ideal decisions.

This was the finding of a several-months-long study conducted by a team led by neuroscientist Professor Dr. med. Markus Ullsperger from the Institute of Psychology at Otto von Guericke University Magdeburg in collaboration with colleagues from the University Clinic for Psychiatry & Psychotherapy and the German Center for Mental Health.

By using electroencephalography (EEG) and complex mathematical computer modeling, the team of researchers discovered that learning deficits in depressive and schizophrenic are caused by diminished/reduced flexibility in the use of new information.

Read more | >

A 26-year-old man with a 1-week history of a rash on his hands and feet and fever had scattered, partially blanchable macules that had merged into erythematous patches on his hands and feet. Read the full clinical case from มหาวิทยาลัยเชียงใหม่ Chiang Mai University:

Images in Clinical Medicine from The New England Journal of Medicine — Papular–Purpuric “Gloves and Socks” Syndrome in Parvovirus B19 Infection.

Read more | >